UnitedHealth Group (UNH) Stock Price, News & Analysis

Company Overview

UnitedHealth Group Inc. is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs. It delivers plan design, claims processing, care management and provider network services, and operates programs tailored to Medicare Advantage and Medicaid populations. The business emphasizes integrating clinical programs and care coordination to support member access to providers and manage utilization.

Optum provides health services and technology solutions across care delivery, pharmacy services and data analytics. Its units include care delivery and ambulatory services, pharmacy care services that manage prescription benefits and dispensing, and technology and information services that supply analytics, consulting and administrative platforms to health systems, payers and life sciences companies. Optum’s focus is on using clinical and operational data, care management capabilities and technology to improve outcomes, lower costs and support health system partners.

UnitedHealth Group serves primarily the U.S. market while extending capabilities and services globally through its enterprise businesses. The company has grown through a combination of internal development and strategic investments in care delivery, pharmacy and health technology. Andrew Witty has served as chief executive officer since 2021, leading the company’s efforts to integrate insurance products with health services and technology to address evolving provider, payer and consumer needs.

Key Stats

• Today's Range: $400.66 to $410.64
• 50-Day Range: $377.93 to $436.19
• 52-Week Range: $244.37 to $461.62
• Volume: 4.09 million shs
• Average Volume: 5.50 million shs
• Market Capitalization: $369.20 billion
• P/E Ratio: 26.16
• Dividend Yield: 2.28%
• Price Target: $455.92
• Consensus Rating: Moderate Buy

UnitedHealth Group Stock Analysis - MarketRank™

UnitedHealth Group scored higher than 99% of companies evaluated by MarketBeat, and ranked 4th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

UnitedHealth Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 2 strong buy ratings, 20 buy ratings, 5 hold ratings, and no sell ratings.

Upside Potential

UnitedHealth Group has a consensus price target of $455.92, representing about 12.1% upside from its current price of $406.54.

Amount of Analyst Coverage

UnitedHealth Group has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 13.86%

Earnings Growth

Earnings for UnitedHealth Group are expected to grow by 13.86% in the coming year, from $19.69 to $22.42 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of UnitedHealth Group is 26.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.33.

Price to Earnings Ratio vs. Sector

The P/E ratio of UnitedHealth Group is 26.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.11.

Price to Earnings Growth Ratio

UnitedHealth Group has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

UnitedHealth Group has a P/B Ratio of 3.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.91% of the float of UnitedHealth Group has been sold short.

Short Interest Ratio / Days to Cover

UnitedHealth Group has a short interest ratio ("days to cover") of 3.46, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in UnitedHealth Group has recently decreased by 5.82%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

UnitedHealth Group pays a meaningful dividend of 2.28%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

UnitedHealth Group has been increasing its dividend for 15 years.

Dividend Coverage

The dividend payout ratio of UnitedHealth Group is 59.72%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 41.39% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.6 / 5
• News Sentiment: 1.33

News Sentiment

UnitedHealth Group has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 36 news articles for UnitedHealth Group this week, compared to 11 articles on an average week.

Search Interest

107 people have searched for UNH on MarketBeat in the last 30 days. This is an increase of 2% compared to the previous 30 days.

MarketBeat Follows

51 people have added UnitedHealth Group to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, UnitedHealth Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $205,000.00 in company stock.

Percentage Held by Insiders

0.19% of the stock of UnitedHealth Group is held by insiders.

Percentage Held by Institutions

87.86% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 6/23 Dividend: 6/15/2026
• Ex-Dividend for 6/23 Dividend: 6/15/2026
• Dividend Payable: 6/23/2026
• Last Earnings: 7/16/2026
• Today: 8/09/2026
• Next Earnings (Estimated): 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NYSE:UNH
• CIK: 731766
• Web: www.unitedhealthgroup.com
• Phone: (952) 936-1300
• Fax: 952-936-1819
• Employees: 390,000
• Year Founded: 1977

Price Target and Rating

• Average Price Target for UnitedHealth Group: $455.92
• High Price Target: $529.00
• Low Price Target: $330.00
• Potential Upside/Downside: +12.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 27 Analysts

Profitability

• EPS (Trailing Twelve Months): $15.54
• Trailing P/E Ratio: 26.16
• Forward P/E Ratio: 20.65
• P/E Growth: 1.41
• Net Income: $12.06 billion
• Net Margins: 3.14%
• Pretax Margin: 3.87%
• Return on Equity: 16.53%
• Return on Assets: 5.43%

Debt

• Debt-to-Equity Ratio: 0.66
• Current Ratio: 0.78
• Quick Ratio: 0.80

Sales & Book Value

• Annual Sales: $447.57 billion
• Price / Sales: 0.82
• Cash Flow: $21.23 per share
• Price / Cash Flow: 19.15
• Book Value: $115.08 per share
• Price / Book: 3.53

Miscellaneous

• Outstanding Shares: 908,140,000
• Free Float: 906,419,000
• Market Cap: $369.20 billion
• Optionable: Optionable
• Beta: 0.62